First-line treatment of advanced ovarian cancer: an expert update
Ovarian cancer is the fifth most common cause of death among malignant diseases in women in Europe. The standard treatment is cytoreductive surgery, followed by platinum-taxane based chemotherapy. In patients with advanced disease, a valid option is a neoadjuvant chemotherapy followed by interval de...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University Hospital for Tumors
2020-01-01
|
| Series: | Libri Oncologici |
| Subjects: | |
| Online Access: | https://hrcak.srce.hr/file/364247 |